RHONDA HILL: Open Payments
NPI 1235432154 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,191 in 72 payments from 19 companies in 2025. Trend: 2023 $753 · 2024 $885 · 2025 $1,191
Food & beverage: $1,191
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $312 |
| AstraZeneca Pharmaceuticals LP | 6 | $180 |
| Novo Nordisk Inc | 10 | $160 |
| Lilly USA, LLC | 4 | $84 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| Alkermes, Inc. | 3 | $58 |
| PFIZER INC. | 2 | $43 |
| Edwards Lifesciences Corporation | 1 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Exact Sciences Corporation | 2 | $30 |
Products named: QULIPTA, FARXIGA, VRAYLAR, MOUNJARO, ARISTADA, Wegovy, Rybelsus, Ozempic.
Industry payments across SC — which companies pay providers there.
